Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.

OBJECTIVE: To determine whether the immunogenicity of a single dose infant priming schedule of serogroup C meningococcal (MenC) conjugate vaccine is non-inferior to a two dose priming schedule when followed by a booster dose at age 12 months. DESIGN: Phase IV open label randomised controlled trial c...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Pace, D, Khatami, A, McKenna, J, Campbell, D, Attard-Montalto, S, Birks, J, Voysey, M, White, C, Finn, A, Macloed, E, Faust, S, Kent, A, Heath, P, Borrow, R, Snape, M, Pollard, A
التنسيق:	Journal article
اللغة:	English
منشور في:	BMJ Publishing Group 2015

مواد مشابهة

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
حسب: Pace, D, وآخرون
منشور في: (2016)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
حسب: De Whalley, P, وآخرون
منشور في: (2013)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
حسب: de Whalley, P, وآخرون
منشور في: (2013)

Will booster doses be required for serogroup B meningococcal vaccine?
حسب: McQuaid, F, وآخرون
منشور في: (2014)

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
حسب: Pollard, A, وآخرون
منشور في: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
حسب: Snape, MD, وآخرون
منشور في: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
حسب: Snape, M, وآخرون
منشور في: (2013)

Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
حسب: Snape, MD, وآخرون
منشور في: (2010)

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines - exploratory analyses within a randomised controlled trial
حسب: Khatami, A, وآخرون
منشور في: (2014)

Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age
حسب: Snape, M, وآخرون
منشور في: (2015)

Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
حسب: Khatami, A, وآخرون
منشور في: (2011)

Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.
حسب: Khatami, A, وآخرون
منشور في: (2011)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
حسب: Blanchard-Rohner, G, وآخرون
منشور في: (2012)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine.
حسب: Blanchard-Rohner, G, وآخرون
منشور في: (2012)

Serogroup B meningococcal vaccines-an unfinished story.
حسب: Sadarangani, M, وآخرون
منشور في: (2010)

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
حسب: Snape, MD, وآخرون
منشور في: (2009)

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales - Authors' reply
حسب: Snape, MD, وآخرون
منشور في: (2006)

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
حسب: Snape, M, وآخرون
منشور في: (2008)

Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study.
حسب: Snape, MD, وآخرون
منشور في: (2008)

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines--exploratory analyses within a randomised controlled trial.
حسب: Ameneh Khatami, وآخرون
منشور في: (2014-01-01)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
حسب: Read, R, وآخرون
منشور في: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
حسب: Read, R, وآخرون
منشور في: (2014)

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.
حسب: Snape, MD, وآخرون
منشور في: (2005)

Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: a follow-on study to a randomized clinical trial.
حسب: Snape, MD, وآخرون
منشور في: (2013)

Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: A follow-on study to a randomized clinical trial
حسب: Snape, MD, وآخرون
منشور في: (2013)

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
حسب: Snape, MD, وآخرون
منشور في: (2006)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
حسب: Snape, M, وآخرون
منشور في: (2006)

Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
حسب: Iro, M, وآخرون
منشور في: (2015)

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.
حسب: Perrett, K, وآخرون
منشور في: (2010)

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial
حسب: Perrett, K, وآخرون
منشور في: (2010)

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
حسب: Gossger, N, وآخرون
منشور في: (2012)

Challenges and progress in the development of a serogroup B meningococcal vaccine.
حسب: Lewis, S, وآخرون
منشور في: (2009)

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine
حسب: O'Connor, D, وآخرون
منشور في: (2014)

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine.
حسب: O'Connor, D, وآخرون
منشور في: (2014)

Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age.
حسب: McQuaid, F, وآخرون
منشور في: (2014)

B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.
حسب: Perrett, K, وآخرون
منشور في: (2012)

Meningococcal disease serogroup C
حسب: Cuevas IE, وآخرون
منشور في: (2012-03-01)

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
حسب: Xie, O, وآخرون
منشور في: (2013)

The beginning of the end for serogroup B meningococcus?
حسب: Snape, MD, وآخرون
منشور في: (2013)

The beginning of the end for serogroup B meningococcus?
حسب: Snape, MD, وآخرون
منشور في: (2013)